Literature DB >> 20621903

Aggregating and disaggregating patients in clinical trials and their subgroup analyses.

David M Kent, Peter K Lindenauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20621903      PMCID： PMC2946839          DOI： 10.7326/0003-4819-153-1-201007060-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Venous thromboembolism prophylaxis among medical patients at US hospitals.

Authors:  Michael B Rothberg; Maureen Lahti; Penelope S Pekow; Peter K Lindenauer
Journal:  J Gen Intern Med       Date:  2010-03-30       Impact factor: 5.128

2.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

3.  Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses.

Authors:  Xin Sun; Matthias Briel; Stephen D Walter; Gordon H Guyatt
Journal:  BMJ       Date:  2010-03-30

4.  Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.

Authors:  Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer-Michel Samama; Philippe Nicol; Eric Vicaut; Alexander G G Turpie; Roger D Yusen
Journal:  Ann Intern Med       Date:  2010-07-06       Impact factor: 25.391

5.  Therapeutic innovations, diminishing returns, and control rate preservation.

Authors:  David M Kent; Thomas A Trikalinos
Journal:  JAMA       Date:  2009-11-25       Impact factor: 56.272

6.  An evidence based approach to individualising treatment.

Authors:  P P Glasziou; L M Irwig
Journal:  BMJ       Date:  1995-11-18
  6 in total
  5 in total

1.  Infectious disease: do steroids benefit patients with bacterial meningitis?

Authors:  Vincent Quagliarello; W Michael Scheld
Journal:  Nat Rev Neurol       Date:  2010-10       Impact factor: 42.937

Review 2.  Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.

Authors:  Ann M O'Hare; Rudolph A Rodriguez; Christopher Barrett Bowling
Journal:  Nephrol Dial Transplant       Date:  2015-01-29       Impact factor: 5.992

Review 3.  Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research.

Authors:  Sheldon Greenfield; Sherrie H Kaplan
Journal:  J Comp Eff Res       Date:  2012-05       Impact factor: 1.744

4.  Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model.

Authors:  Jenica N Upshaw; David van Klaveren; Marvin A Konstam; David M Kent
Journal:  Am J Med       Date:  2017-12-25       Impact factor: 4.965

5.  Predictability of persistent frequent attendance in primary care: a temporal and geographical validation study.

Authors:  Frans T Smits; Henk J Brouwer; Aeilko H Zwinderman; Marjan van den Akker; Ben van Steenkiste; Jacob Mohrs; Aart H Schene; Henk C van Weert; Gerben Ter Riet
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.